Clinical trials
Observational alpha 1-Antitrypsin Deficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 9 |
| Unknown status | 6 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| University of Florida | 4 |
| Columbia University | 3 |
| Medical University of South Carolina | 3 |
| Alpha-1 Foundation | 2 |
| Arbor Research Collaborative for Health | 2 |
| Assiut University | 2 |
| University Hospital, Bordeaux | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| alpha 1-Antitrypsin Deficiency | 45 |
| Pulmonary Disease, Chronic Obstructive | 11 |
| Emphysema | 8 |
| Genetic Diseases, Inborn | 5 |
| Cystic Fibrosis | 4 |
| Lung Diseases | 3 |
| Alagille Syndrome | 2 |
| Cholestasis | 2 |
| Fibrosis | 2 |
| Inflammation | 2 |
Trials
Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.